{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T12:16:53Z","timestamp":1762431413984},"reference-count":40,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2018,4,1]],"date-time":"2018-04-01T00:00:00Z","timestamp":1522540800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["redjournal.org","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Radiation Oncology*Biology*Physics"],"published-print":{"date-parts":[[2018,4]]},"DOI":"10.1016\/j.ijrobp.2018.01.002","type":"journal-article","created":{"date-parts":[[2018,1,6]],"date-time":"2018-01-06T04:29:42Z","timestamp":1515212982000},"page":"1119-1125","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Patterns of Involved-Field Radiation Therapy Protocol Deviations in Pediatric Versus Adolescent and Young Adults With Hodgkin Lymphoma: A Report From the Children's Oncology Group AHOD0031"],"prefix":"10.1016","volume":"100","author":[{"given":"Aaron","family":"Parzuchowski","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rizvan","family":"Bush","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qinglin","family":"Pei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Debra L.","family":"Friedman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas J.","family":"FitzGerald","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Suzanne L.","family":"Wolden","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kavita V.","family":"Dharmarajan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Louis S.","family":"Constine","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fran","family":"Laurie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sandy K.","family":"Kessel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Burton","family":"Appel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karen","family":"Fernandez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Angela","family":"Punnett","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cindy L.","family":"Schwartz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jacob","family":"Cox","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephanie A.","family":"Terezakis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijrobp.2018.01.002_bib1","doi-asserted-by":"crossref","first-page":"83","DOI":"10.3322\/caac.21219","article-title":"Childhood and adolescent cancer statistics","volume":"64","author":"Ward","year":"2014","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.ijrobp.2018.01.002_bib2","doi-asserted-by":"crossref","first-page":"2051","DOI":"10.1182\/blood-2008-10-184143","article-title":"A risk-adapted, response-based approach using ABVE-PC for children and adolescents with intermediate- and high-risk Hodgkin lymphoma: The results of P9425","volume":"114","author":"Schwartz","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.ijrobp.2018.01.002_bib3","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1200\/JCO.2006.08.4772","article-title":"Final results of a prospective clinical trial with VAMP and low-dose involved-field radiation for children with low-risk Hodgkin's disease","volume":"25","author":"Donaldson","year":"2007","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2018.01.002_bib4","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1055\/s-2003-39372","article-title":"Preliminary results of the multicenter trial GPOH-HD 95 for the treatment of Hodgkin's disease in children and adolescents: Analysis and outlook","volume":"215","author":"D\u00f6rffel","year":"2003","journal-title":"Klin Padiatr"},{"key":"10.1016\/j.ijrobp.2018.01.002_bib5","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1200\/JCO.1998.16.3.897","article-title":"MOPP or radiation in addition to ABVD in the treatment of pathologically staged advanced Hodgkin's disease in children: Results of the Children's Cancer Group phase III trial","volume":"16","author":"Hutchinson","year":"1998","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2018.01.002_bib6","doi-asserted-by":"crossref","first-page":"2596","DOI":"10.1182\/blood-2010-05-285379","article-title":"BEACOPP chemotherapy is a highly effective regimen in children and adolescents with high-risk Hodgkin lymphoma: A report from the Children's Oncology Group","volume":"117","author":"Kelly","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.ijrobp.2018.01.002_bib7","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1097\/00043426-200606000-00008","article-title":"POG 8625: A randomized trial comparing chemotherapy with chemoradiotherapy for children and adolescents with stages I, IIA, IIIA1 Hodgkin disease: A report from the Children's Oncology Group","volume":"28","author":"Kung","year":"2006","journal-title":"J Pediatr Hematol Oncol"},{"key":"10.1016\/j.ijrobp.2018.01.002_bib8","doi-asserted-by":"crossref","first-page":"3765","DOI":"10.1200\/JCO.2002.12.007","article-title":"Randomized comparison of low-dose involved-field radiotherapy and no radiotherapy for children with Hodgkin's disease who achieve a complete response to chemotherapy","volume":"20","author":"Nachman","year":"2002","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2018.01.002_bib9","doi-asserted-by":"crossref","first-page":"3088","DOI":"10.1200\/JCO.2002.03.051","article-title":"Treatment of unfavorable childhood Hodgkin's disease with VEPA and low-dose, involved-field radiation","volume":"20","author":"Friedmann","year":"2002","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2018.01.002_bib10","doi-asserted-by":"crossref","first-page":"3174","DOI":"10.1200\/JCO.2011.41.1819","article-title":"Long-term results of CCG 5942: A randomized comparison of chemotherapy with and without radiotherapy for children with Hodgkin's lymphoma\u2014A report from the Children's Oncology Group","volume":"30","author":"Wolden","year":"2012","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2018.01.002_bib11","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1016\/S0360-3016(03)00125-1","article-title":"Does bulky disease at diagnosis influence outcome in childhood Hodgkin's disease and require higher radiation doses? Results from the German-Austrian Pediatric Multicenter trial DAL-HD-90","volume":"56","author":"Dieckmann","year":"2003","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2018.01.002_bib12","doi-asserted-by":"crossref","first-page":"1971","DOI":"10.1200\/JCO.1990.8.12.1971","article-title":"Efficacy and toxicity of 12 courses of ABVD chemotherapy followed by low-dose regional radiation in advanced Hodgkin's disease in children: A report from the Children's Cancer Study group","volume":"8","author":"Fryer","year":"1990","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2018.01.002_bib13","doi-asserted-by":"crossref","first-page":"3680","DOI":"10.1200\/JCO.2009.26.9381","article-title":"Procarbazine-free OEPA-COPDAC chemotherapy in boys and standard OPPA-COPP in girls have comparable effectiveness in pediatric Hodgkin's lymphoma: The GPOH-HD-2002 study","volume":"28","author":"Mauz-K\u00f6rholz","year":"2010","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2018.01.002_bib14","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1002\/pbc.24279","article-title":"Response-dependent and reduced treatment in lower risk Hodgkin lymphoma in children and adolescents, results of P9426: A report from the Children's Oncology Group","volume":"59","author":"Tebbi","year":"2012","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.ijrobp.2018.01.002_bib15","doi-asserted-by":"crossref","first-page":"2769","DOI":"10.1200\/JCO.1997.15.8.2769","article-title":"Randomized study of intensive MOPP-ABVD with or without low-dose total-nodal radiation therapy in the treatment of stages IIB, IIIA2, IIIB, and IV Hodgkin's disease in pediatric patients: A Pediatric Oncology Group study","volume":"15","author":"Weiner","year":"1997","journal-title":"J Clin Oncol"},{"issue":"1 Suppl","key":"10.1016\/j.ijrobp.2018.01.002_bib16","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1093\/annonc\/13.S1.86","article-title":"Early response to chemotherapy: A surrogate for final outcome of Hodgkin's disease patients that should influence initial treatment length and intensity?","volume":"13","author":"Carde","year":"2002","journal-title":"Ann Oncol"},{"key":"10.1016\/j.ijrobp.2018.01.002_bib17","doi-asserted-by":"crossref","first-page":"2609","DOI":"10.1001\/jama.2012.5847","article-title":"Association between radiotherapy vs no radiotherapy based on early response to VAMP chemotherapy and survival among children with favorable-risk Hodgkin lymphoma","volume":"307","author":"Metzger","year":"2012","journal-title":"JAMA"},{"key":"10.1016\/j.ijrobp.2018.01.002_bib18","doi-asserted-by":"crossref","first-page":"3651","DOI":"10.1200\/JCO.2013.52.5410","article-title":"Dose-intensive response-based chemotherapy and radiation therapy for children and adolescents with newly diagnosed intermediate-risk Hodgkin lymphoma: A report from the Children's Oncology Group Study AHOD0031","volume":"32","author":"Friedman","year":"2014","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2018.01.002_bib19","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.ijrobp.2014.10.042","article-title":"Patterns of relapse from a phase 3 study of response-based therapy for intermediate-risk Hodgkin lymphoma (AHOD0031): A report from the Children's Oncology Group","volume":"92","author":"Dharmarajan","year":"2015","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2018.01.002_bib20","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1016\/j.ijrobp.2014.11.034","article-title":"Radiotherapy quality assurance report from Children's Oncology Group AHOD0031","volume":"91","author":"Dharmarajan","year":"2015","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2018.01.002_bib21","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1016\/j.ijrobp.2010.11.039","article-title":"Failure to adhere to protocol specified radiation therapy guidelines was associated with decreased survival in RTOG 9704-A phase III trial of adjuvant chemotherapy and chemoradiotherapy for patients with resected adenocarcinoma of the pancreas","volume":"82","author":"Abrams","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2018.01.002_bib22","doi-asserted-by":"crossref","first-page":"2996","DOI":"10.1200\/JCO.2009.27.4498","article-title":"Critical impact of radiotherapy protocol compliance and quality in the treatment of advanced head and neck cancer: Results from TROG 02.02","volume":"28","author":"Peters","year":"2010","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2018.01.002_bib23","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1093\/jnci\/djt001","article-title":"Radiotherapy protocol deviations and clinical outcomes: A meta-analysis of cooperative group clinical trials","volume":"105","author":"Ohri","year":"2013","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.ijrobp.2018.01.002_bib24","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.ijrobp.2013.03.036","article-title":"Does quality of radiation therapy predict outcomes of multicenter cooperative group trials? A literature review","volume":"87","author":"Fairchild","year":"2013","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2018.01.002_bib25","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.semradonc.2011.09.004","article-title":"What we have learned: The impact of quality from a clinical trials perspective","volume":"22","author":"FitzGerald","year":"2012","journal-title":"Semin Radiat Oncol"},{"key":"10.1016\/j.ijrobp.2018.01.002_bib26","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1002\/pbc.22190","article-title":"The quid pro quo of pediatric versus adult services for older adolescent cancer patients","volume":"54","author":"Bleyer","year":"2010","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.ijrobp.2018.01.002_bib27","doi-asserted-by":"crossref","first-page":"242","DOI":"10.3322\/canjclin.57.4.242","article-title":"Young adult oncology: The patients and their survival challenges","volume":"57","author":"Bleyer","year":"2007","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.ijrobp.2018.01.002_bib28","series-title":"Cancer Epidemiology in Older Adolescents and Young Adults 15 to 29 Years of Age, Including SEER Incidence and Survival: 1975-2000","first-page":"1","article-title":"Introduction","author":"Bleyer","year":"2006"},{"issue":"S7 Suppl","key":"10.1016\/j.ijrobp.2018.01.002_bib29","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.1002\/cncr.22104","article-title":"Proceedings of a workshop: Bridging the gap in care and addressing participation in clinical trials","volume":"107","author":"Bleyer","year":"2006","journal-title":"Cancer"},{"key":"10.1016\/j.ijrobp.2018.01.002_bib30","doi-asserted-by":"crossref","first-page":"922","DOI":"10.3109\/0284186X.2012.705891","article-title":"Cancer in adolescents and young adults (15\u201329 years): A population-based study in the Netherlands 1989\u20132009","volume":"51","author":"Aben","year":"2012","journal-title":"Acta Oncol"},{"key":"10.1016\/j.ijrobp.2018.01.002_bib31","series-title":"Closing the gap: Research and care imperatives for adolescents and young adults with cancer. NIH Publication No. 06-6067","author":"Adolescent and Young Adult Oncology Progress Review Group","year":"2006"},{"key":"10.1016\/j.ijrobp.2018.01.002_bib32","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.3109\/10428194.2011.648631","article-title":"Adolescents with Hodgkin lymphoma: Old children or young adults?","volume":"53","author":"Eichenauer","year":"2012","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.ijrobp.2018.01.002_bib33","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1159\/000360205","article-title":"The challenging aspects of managing adolescents and young adults with Hodgkin's lymphoma","volume":"132","author":"Jachimowicz","year":"2014","journal-title":"Acta Haematol"},{"issue":"7 Suppl","key":"10.1016\/j.ijrobp.2018.01.002_bib34","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1002\/cncr.22102","article-title":"Adolescents and young adults with cancer: The scope of the problem and criticality of clinical trials","volume":"107","author":"Bleyer","year":"2006","journal-title":"Cancer"},{"key":"10.1016\/j.ijrobp.2018.01.002_bib35","doi-asserted-by":"crossref","first-page":"e60","DOI":"10.1097\/MPH.0b013e3181f4686e","article-title":"Adolescent Hodgkin lymphoma: Are treatment results more favorable with pediatric than with adult regimens?","volume":"33","author":"M\u00fcller","year":"2011","journal-title":"J Pediatr Hematol Oncol"},{"key":"10.1016\/j.ijrobp.2018.01.002_bib36","series-title":"Identifying and Addressing the Needs of Adolescents and Young Adults With Cancer: Workshop Summary","author":"Mass","year":"2013"},{"key":"10.1016\/j.ijrobp.2018.01.002_bib37","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.ijrobp.2008.10.048","article-title":"Patterns and timing of initial relapse in patients subsequently undergoing transplantation for Hodgkin's lymphoma","volume":"75","author":"Dhakal","year":"2009","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2018.01.002_bib38","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.radonc.2005.10.018","article-title":"Site of relapse after chemotherapy alone for stage I and II Hodgkin's disease","volume":"78","author":"Shahidi","year":"2006","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2018.01.002_bib39","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1002\/pbc.24968","article-title":"Patterns of failure after involved field radiation therapy for pediatric and young adult Hodgkin lymphoma","volume":"61","author":"Huynh-Le","year":"2014","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.ijrobp.2018.01.002_bib40","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1038\/nrc2349","article-title":"Biology and Clinical Trials Subgroups of the US National Cancer Institute Progress Review Group in Adolescent and Young Adult Oncology. The distinctive biology of cancer in adolescents and young adults","volume":"8","author":"Bleyer","year":"2008","journal-title":"Nat Rev Cancer"}],"container-title":["International Journal of Radiation Oncology*Biology*Physics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0360301618300026?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0360301618300026?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,10,25]],"date-time":"2020-10-25T08:24:42Z","timestamp":1603614282000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0360301618300026"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4]]},"references-count":40,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2018,4]]}},"alternative-id":["S0360301618300026"],"URL":"https:\/\/doi.org\/10.1016\/j.ijrobp.2018.01.002","relation":{},"ISSN":["0360-3016"],"issn-type":[{"value":"0360-3016","type":"print"}],"subject":[],"published":{"date-parts":[[2018,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Patterns of Involved-Field Radiation Therapy Protocol Deviations in Pediatric Versus Adolescent and Young Adults With Hodgkin Lymphoma: A Report From the Children's Oncology Group AHOD0031","name":"articletitle","label":"Article Title"},{"value":"International Journal of Radiation Oncology*Biology*Physics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijrobp.2018.01.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}